CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM

Main Article Content

DOI

Olena Kolesnikova

kolesnikova1973@gmail.com

http://orcid.org/0000-0001-5606-6621
Olena Vysotska

o.vysotska@khai.edu

http://orcid.org/0000-0003-3723-9771
Anna Potapenko

annav1611sh@gmail.com

http://orcid.org/0000-0002-1658-0156
Anastasia Radchenko

anastasha.radchenko@gmail.com

http://orcid.org/0000-0002-9687-8218
Anna Trunova

a.pecherska@khai.edu

http://orcid.org/0000-0001-7069-0674
Natalia Virstyuk

if_dermven@ukr.net

http://orcid.org/0000-0002-5794-8754
Liudmyla Vasylevska-Skupa

lpvasylevska@gmail.com

http://orcid.org/0000-0002-1989-7175
Aliya Kalizhanova

kalizhanova_aliya@mail.ru

http://orcid.org/0000-0002-5979-9756
Nazerka Mukanova

mukanova0124@gmail.com

http://orcid.org/0009-0002-7945-7187

Abstract

One of the most common diseases of our time is non-alcoholic fatty liver disease (NAFLD). Recently published research results indicate that patients with NAFLD along with traditional risk factors for cardiovascular diseases (CVD) have "new" risk factors such as endothelial dysfunction (ED), carotid intima-media thickness (CIMT), an increase in the CRP level, as well as risk factors combined into the Framingham scale. It is also known that combination of NAFLD with subclinical hypothyroidism (SH) forms an abnormal metabolic phenotype, which is associated with cardiometabolic risk factors. The study of cardiometabolic predictors and vascular markers in patients with NAFLD in combination with SH will provide an opportunity to improve the strategy of cardiovascular events prevention in such comorbid patients.

Keywords:

cardiometabolic risk, non-alcoholic fatty liver disease, subclinical hypothyroidism, prediction, binary regression logistic analysis, validation of prognostic models

References

Article Details

Kolesnikova, O., Vysotska, O., Potapenko, A., Radchenko, A., Trunova, A., Virstyuk, N., … Mukanova, N. (2023). CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM. Informatyka, Automatyka, Pomiary W Gospodarce I Ochronie Środowiska, 13(2), 64–68. https://doi.org/10.35784/iapgos.3654